To re port 2 cases of ad verse re ac tions to St John's wort, a pop u lar herbal treat ment for de pres sion. Method: We pres ent 2 case his to ries and re view the ex ist ing lit er a ture re gard ing St John's wort.
C lin i cal tri als con firm that St John's wort (Hypericum perforatum) ef fec tively re lieves symp toms as so ci ated with mild to mod er ate de pres sion (1, 2) . The mech a nism by which it ex erts this ef fect is cur rently un known. Al though early stud ies noted monoamine oxidase (MAO) in hi bi tion (3) , this find ing has not been con firmed by sub se quent work (4, 5) . In vi tro stud ies have found that St John's wort may reduce the ex pres sion of se ro to nin re cep tors (6) , in crease the num bers of 5-HT1A and 5-HT2A re cep tors (7) , and in hibit synapotosomal se ro to nin up take (8, 9) . It has been ques tioned whether oral ad min is tra tion of St John's wort ex tract produces in vivo con cen tra tions com pa ra ble to those in vi tro stud ies. The gamma-amino bu tyric acid (GABA) re cep tor activ ity of St John's wort has also been in ves ti gated with out con clu sive re sults (10) . Other pu ta tive tar gets of St John's wort in clude melatonin and cytokine ex pres sion, al though these re ports are pre lim i nary. The po ten tial serotonergic action of St John's wort has raised con cerns that it could in ter act with other serotonergic med i ca tions and pro duce sim i lar side ef fects. The first clin i cal cases of se ro to nin syn drome as so ciated with the con cur rent use of St John's wort and pre scription an ti de pres sants (sertraline or nefazodone) have been re cently re ported (11, 12) . We re port an other case of se ro to nin syn drome in a pa tient with a his tory of re ac tions to serotonergic med i ca tions who took St John's wort. In ad dition, we de scribe a case of hair loss, which has not pre vi ously been as so ci ated with in ges tion of St John's wort.
Serotonin Syndrome With St John's Wort
Mr X is a 40-year-old man with a his tory of an anx i ety dis order and de pres sion who pre sented to the emer gency room of a psy chi at ric hos pi tal af ter tak ing 450 mg of St John's wort. The brand and prep a ra tion of the prod uct are un known. He had been tak ing 450 mg daily for the past 10 days for depressed mood. Fol low ing din ner, he de vel oped flush ing, diaphoresis, ag i ta tion, weak ness of the legs, dry mouth, tightness in the chest, and an in abil ity to fo cus. These symp toms dif fered from his usual panic at tacks and did not re spond to his usual anti-anxiety cop ing strat e gies. He de nied ex ces sive use of al co hol. He was cur rently un der go ing cog nitive-behavioural ther apy for so cial pho bia with panic at tacks pre cip i tated by so cial sit u a tions. The panic at tacks im proved with clonazepam 0.5 mg twice daily, which he had been taking for some months. He was on no other med i ca tion.
When he pre sented to the emer gency room, he was hy per tensive (172/120 mm Hg) with out a pos tural drop, his heart rate was 94/min ute and reg u lar, and his res pi ra tion rate was 22/min ute. Mr X be came pro gres sively more con fused over a pe riod of 20 min utes and was dis ori ented re gard ing the month, the year, and the fact that it was the Christ mas sea son.
He did, how ever, know the name of the hos pi tal. He then became quite trem u lous and dizzy and re quired ox y gen to relieve his dyspnea. He com plained of chest tight ness, but he did not com plain of chest pain or ra di a tion. Af ter trans port to a gen eral hos pi tal, his blood pres sure was 150/96 mm Hg, heart rate 90/min ute, and reg u lar and res pi ra tion rate was 20/min ute. A neu ro log i cal ex am i na tion and elec tro car diogram were nor mal. Af ter some hours of ob ser va tion, Mr X felt better, and his blood pres sure nor mal ized at 135/88 mm Hg, at which point he was dis charged with a di ag no sis of an ad verse drug re ac tion to St John's wort.
In the past, Mr X had ex pe ri enced manic symp toms at the age of 37, fol low ing treat ment with a se lec tive se ro to nin reuptake in hib i tor (SSRI) for a de pressed mood. He had had 2 ad missions to hos pi tal: the first was for a pe riod of 3 weeks in July 1996 when, at the age of 38, he ex pe ri enced a ma jor de pressive ep i sode with psy chotic fea tures and sui cidal ideation. He also had manic symp toms fol low ing treat ment with an SSRI. He en dorsed a 7-month prior his tory of heavy al co hol use and oc ca sional binges as a teen ager. He was treated with venlafaxine 37.5 mg twice daily and lorazepam 1 mg as needed, up to 4 mg daily. His sec ond ad mis sion, in Au gust 1996, for sui cidal ideation due to marked psychosocial stressors, oc curred 2 weeks af ter dis charge. There were no psychotic fea tures, and he re ceived a di ag no sis of ad just ment dis or der with de pressed mood. His blood pres sure on this admis sion was 160/110, with tachy car dia and di ar rhea that normal ized upon stop ping the venlafaxine. He was dis charged on lorazepam 1 mg daily and re ferred to a re lax ation ther apy group and to the care of his com mu nity psy chi a trist. While he was an out pa tient, lorazepam was later changed to clonazepam.
Serotonin Syndrome
There have been many re ports in the lit er a ture of se ro to nin syn drome oc cur ring with var i ous sin gle agents or com bi nations of med i ca tions, in clud ing SSRIs, MAOIs, clomipramine, clorgyline, lith ium, carbamazepine, benzodiazepines, bromocriptine, L-dopa/carbidopa, levothyroxine, and oth ers. Usually, the syn drome is seen in com bi na tions of serotomimetic agents with MAOIs, de velops af ter ini ti a tion or dose in creases, and may be dose-dependent (13) . The typ i cal signs and symp toms of sero to nin syn drome in clude changes in men tal sta tus (ag i ta tion, con fu sion, hypomania, rest less ness, dis ori en ta tion, or coma), au to nomic changes (diaphoresis, flush ing, blood pres sure lability, tachy car dia, tachypnea, pupillary changes, or low-grade fe ver), and neuromuscular changes (tremor, hyperreflexia, myoclonus, ri gid ity, or incoordination), in addi tion to head ache, nau sea, anx i ety, di ar rhea and shiv er ing (13) (14) (15) . There are no re li able lab o ra tory changes to help in the de tec tion of this syn drome; thus, the di ag no sis is a clin i cal one. There are spo radic re ports of mild leukocytosis and in creased creatinine kinase (CK). In se vere cases, sei zures, nys tag mus, opisthotonus, re nal fail ure, car diac arrhythmias, coma, and death can oc cur (15) .
It has been hy poth e sized that ac ti va tion of the 5-HT 1A re ceptor is in volved in the pathophysiology of se ro to nin syn drome. Other hy poth e ses in clude stim u la tion or mod i fi ca tion of se roto nin re cep tors in the dor sal and me dian raphe nu cleus in the brainstem (the main lo ca tion for se ro to nin neu ron cell bodies), en hance ment of over all 5-HT trans mis sion, and combined ac ti va tion of cy clic adenosine monophosphate (cAMP)-re lated 5-HT 1A re cep tors and phosphotidyl hy dro lysis-linked 5-HT 2 re cep tors (15) . The in ci dence of se ro to nin syn drome is un known. It is likely un der-reported, and it can be con fused with neuroleptic ma lig nant syn drome (16) . Treat ment in cludes prompt rec og ni tion, re moval of the offend ing agent(s), close ob ser va tion un til res o lu tion, and the use of such var i ous sup port ive mea sures as ad e quate hydration, at ten tion to elec tro lyte and acid-base bal ances, cool ing baths, and antipyretics (17) . No ben e fit has been dem on strated with the use of benzodiazepines, anticholinergics, antihistaminergics, chlorpromazine, muscle re lax ants, and mem brane sta bi liz ers such as dantrolene (14) . An ec dotal use of cyproheptadine, a se ro to nin an tag onist, and methysurgide have been re ported to de crease the dura tion of this syn drome, which is usu ally short-lived (14) . In the case of Mr X, the pos si bil ity that in ges tion of St John's wort caused se ro to nin syn drome is sup ported by the chro nology of events and the fact that he has ex pe ri enced prior adverse re ac tions to serotonergic med i ca tions. Other pos si ble causes for his symp toms in clude an atyp i cal panic at tack and an ad verse re ac tion to some thing he ate at din ner.
Hair Loss With St John's Wort
Ms X, a 24-year-old, uni ver sity-educated woman, be gan suffer ing non spe cific symp toms in 1996, for which she was prescribed herbal rem e dies by her tra di tional Chi nese med i cine prac ti tio ner. She sub se quently de vel oped prom i nent paranoid de lu sions of ref er ence from the ra dio and from tele vision, ac com pa nied by de lu sions of thought broad cast ing and grandiosity, and was di ag nosed with schizo phre nia in 1997. Her psy chotic symp toms re sponded well to treat ment with olanzapine at a dose of be tween 5 mg to 10 mg daily. Be ginning in June 1998, still on olanzapine and feel ing de pressed, Ms X be gan tak ing St John's wort at a dose of 300 mg 3 times daily. Five months af ter ini ti at ing St John's wort, she be gan to ex pe ri ence hair loss on both her scalp and eye brows that persisted for 12 months. She had no his tory of med i cal ill nesses, and he ma tol ogy re sults, in clud ing CBC, dif fer en tial, and micros copy were nor mal. Clin i cal chem is try, in clud ing creatinine, to tal bil i ru bin, al ka line phosphatase, aspartate transaminase (AST) and thy roid-stimulating hor mone (TSH) were nor mal. Prolactin was slightly el e vated at 51mg/L (second ary to olanzapine). Mi cro scopic ex am i na tion of hairs
